The aim of this study was to verify the capability of an MIRD formula‐based dosimetric
method to predict radioiodine kinetics (fraction of administered iodine transferred to the …

Radioiodine has been in use for over as a treatment for hyperthyroidism. Major changes in
clinical practice have led to accurate dosimetry capable of avoiding the risks of adverse …

Calculation of the therapeutic activity of radioiodine 131 I for individualized dosimetry in the
treatment of Graves' disease requires an accurate estimate of the thyroid absorbed radiation …

The traditional algorithms (Marinelli–Quimby and MIRD) used for the absorbed dose
calculation in radionuclide therapy generally assume that the mass of the target organs does …

Due to its high success rate and non-invasive character, an increasing demand for
radioiodine therapy can be seen. This study was conducted to determine whether …

Radioiodine therapy is an effective and safe treatment of hyperthyroidism due to Graves'
disease, toxic adenoma, toxic multinodular goiter. We compared the outcomes of a …

The activity to be administered in I-131 therapy of benign thyroid disease is determined by
the radiation absorbed dose necessary to cure the disease, the target mass, and the …

Purpose: The precise determination of organ mass (mth) and total number of disintegrations
within the thyroid gland () are essential for thyroid absorbed‐dose calculations for …

The aim of this study was to determine the significance of the radioiodine uptake test for
predicting the kinetics of therapeutic 131I doses in the treatment of benign thyroid disorders …

The approximations in the equations used for the calculation of the radioiodine therapy are
reviewed and compared with a reference formula, based on ICRP Publication 30. Applying …